ATOPIC DERMATITIS
RESEARCH STUDY

The goal of the study is to evaluate the immune response to vaccinations for patients receiving the study drug.

Atopic Dermatitis — also known as eczema — is a condition that makes your skin red and itchy. There is no cure for eczema, but researchers are focused more than ever on trying to find ways to treat it. Researchers all over the world are testing an investigational drug called nemolizumab for the treatment of eczema.

Local researchers need volunteers in your area who have had eczema for at least two years to see whether nemolizumab will have any effect on the way the immune system responds to common vaccines.

To Qualify, You:

Are 12-54 years old
Have had eczema for at least 2 years
Have eczema that covers at least 10% of your body
Have used another eczema treatment or cream in the last 6 months that didn’t fully treat your Eczema

Participants Will Receive at No Cost:

Study-related medical care at no cost
Study medication at no cost
Study-related tests

Please answer the following questions to see if you or your child may be eligible:

Were you or the potential participant (if filling this out for them) diagnosed with eczema at least 2 years ago?

Yes

Please select your choice

Does your or the potential participant's (if filling this out for them) eczema cover 10% or more of the body?

Yes

Please select your choice

Would you or the potential participant (if filling this out for them) be willing to receive two common approved vaccines as part of the study procedures?

Yes

Please select your choice

ATOPIC DERMATITISRESEARCH STUDY

The goal of the study is to evaluate the immune response to vaccinations for patients receiving the study drug.

To Qualify, You:

Participants Will Receive at No Cost:

ATOPIC DERMATITIS
RESEARCH STUDY